Wall Street is asking how weight-loss drugs will affect consumer giants — but it may be too early to tell

Delta, Pepsi, Philip Morris International and Darden Restaurants just some names facing questions about how weight-loss drugs could affect their bottom line.

from Health and Science https://ift.tt/HYj7hqv
https://ift.tt/5KMWx0t
https://ift.tt/PJ4pvXj